Clinicogenomic landscape and outcomes of metastatic colorectal cancer patients with pathogenic GNAS variants. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...

HIPEC combined with camrelizumab, paclitaxel and S-1 for conversion therapy in patients with advanced gastric cancer with peritoneal metastasis: A prospective phase II clinical study. This is an ASCO ...

1Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. *Corresponding Author: M.H. Chui, Department of Pathology and Laboratory Medicine, ...

Study results show that DecisionDx-Melanoma was associated with a 32% reduction in mortality risk compared to untested ...

Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced new data to be presented from the Beta-CORRECT clinical validation study at the 2025 American ...

Annual Meeting held in Chicago, IL, was host to a State of the Science session on novel diagnostics and therapeutics in renal cell and urothelial carcinomas. Dr. Michael Hofman presented an in-depth ...